These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 23061320)

  • 1. A study of ayahuasca use in North America.
    Harris R; Gurel L
    J Psychoactive Drugs; 2012; 44(3):209-15. PubMed ID: 23061320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug tourism or spiritual healing? Ayahuasca seekers in Amazonia.
    Winkelman M
    J Psychoactive Drugs; 2005 Jun; 37(2):209-18. PubMed ID: 16149335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered states of consciousness and short-term psychological after-effects induced by the first time ritual use of ayahuasca in an urban context in Brazil.
    Barbosa PC; Giglio JS; Dalgalarrondo P
    J Psychoactive Drugs; 2005 Jun; 37(2):193-201. PubMed ID: 16149333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of creative expression and entoptic phenomena as after-effects of repeated ayahuasca ceremonies.
    Frecska E; Móré CE; Vargha A; Luna LE
    J Psychoactive Drugs; 2012; 44(3):191-9. PubMed ID: 23061318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in spirituality among ayahuasca ceremony novice participants.
    Trichter S; Klimo J; Krippner S
    J Psychoactive Drugs; 2009 Jun; 41(2):121-34. PubMed ID: 19705674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypotheses regarding the mechanisms of ayahuasca in the treatment of addictions.
    Liester MB; Prickett JI
    J Psychoactive Drugs; 2012; 44(3):200-8. PubMed ID: 23061319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Report on psychoactive drug use among adolescents using ayahuasca within a religious context.
    Doering-Silveira E; Grob CS; de Rios MD; Lopez E; Alonso LK; Tacla C; Da Silveira DX
    J Psychoactive Drugs; 2005 Jun; 37(2):141-4. PubMed ID: 16149326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of ayahuasca on psychometric measures of anxiety, panic-like and hopelessness in Santo Daime members.
    Santos RG; Landeira-Fernandez J; Strassman RJ; Motta V; Cruz AP
    J Ethnopharmacol; 2007 Jul; 112(3):507-13. PubMed ID: 17532158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sub-acute and long-term effects of ayahuasca on affect and cognitive thinking style and their association with ego dissolution.
    Uthaug MV; van Oorsouw K; Kuypers KPC; van Boxtel M; Broers NJ; Mason NL; Toennes SW; Riba J; Ramaekers JG
    Psychopharmacology (Berl); 2018 Oct; 235(10):2979-2989. PubMed ID: 30105399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ayahuasca use in cross-cultural perspective.
    de Rios MD; Grob CS
    J Psychoactive Drugs; 2005 Jun; 37(2):119-21. PubMed ID: 16149322
    [No Abstract]   [Full Text] [Related]  

  • 11. Ayahuasca: Psychological and Physiologic Effects, Pharmacology and Potential Uses in Addiction and Mental Illness.
    Hamill J; Hallak J; Dursun SM; Baker G
    Curr Neuropharmacol; 2019; 17(2):108-128. PubMed ID: 29366418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experiences of encounters with ayahuasca--"the vine of the soul".
    Kjellgren A; Eriksson A; Norlander T
    J Psychoactive Drugs; 2009 Dec; 41(4):309-15. PubMed ID: 20235436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autonomic, neuroendocrine, and immunological effects of ayahuasca: a comparative study with d-amphetamine.
    Dos Santos RG; Valle M; Bouso JC; Nomdedéu JF; Rodríguez-Espinosa J; McIlhenny EH; Barker SA; Barbanoj MJ; Riba J
    J Clin Psychopharmacol; 2011 Dec; 31(6):717-26. PubMed ID: 22005052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of ayahuasca on sensory and sensorimotor gating in humans as measured by P50 suppression and prepulse inhibition of the startle reflex, respectively.
    Riba J; Rodríguez-Fornells A; Barbanoj MJ
    Psychopharmacology (Berl); 2002 Dec; 165(1):18-28. PubMed ID: 12474114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The globalization of ayahuasca: harm reduction or benefit maximization?
    Tupper KW
    Int J Drug Policy; 2008 Aug; 19(4):297-303. PubMed ID: 18638702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and side effects of ayahuasca in humans--an overview focusing on developmental toxicology.
    dos Santos RG
    J Psychoactive Drugs; 2013; 45(1):68-78. PubMed ID: 23662333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased frontal and paralimbic activation following ayahuasca, the pan-Amazonian inebriant.
    Riba J; Romero S; Grasa E; Mena E; Carrió I; Barbanoj MJ
    Psychopharmacology (Berl); 2006 May; 186(1):93-8. PubMed ID: 16575552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the therapeutic potential of Ayahuasca: acute intake increases mindfulness-related capacities.
    Soler J; Elices M; Franquesa A; Barker S; Friedlander P; Feilding A; Pascual JC; Riba J
    Psychopharmacology (Berl); 2016 Mar; 233(5):823-9. PubMed ID: 26612618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ayahuasca and the process of regulation in Brazil and internationally: implications and challenges.
    Labate BC; Feeney K
    Int J Drug Policy; 2012 Mar; 23(2):154-61. PubMed ID: 21856141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ayahuasca Users in Estonia: Ceremonial Practices, Subjective Long-Term Effects, Mental Health, and Quality of Life.
    Kaasik H; Kreegipuu K
    J Psychoactive Drugs; 2020; 52(3):255-263. PubMed ID: 32299306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.